TRPX - Therapix Biosciences Ltd.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.4771
-0.0229 (-4.58%)
At close: 4:00PM EDT

0.5000 +0.02 (4.80%)
Pre-Market: 8:01AM EDT

Stock chart is not supported by your current browser
Previous Close0.5000
Open0.5000
Bid0.4460 x 1400
Ask0.0000 x 3200
Day's Range0.4550 - 0.5000
52 Week Range0.2520 - 4.6900
Volume585,288
Avg. Volume2,000,073
Market Cap2.729M
Beta (5Y Monthly)0.12
PE Ratio (TTM)N/A
EPS (TTM)-2.7980
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • SOL Global Portfolio Company Heavenly Rx, Ltd. Enters Into MOU for Business Combination with Therapix Biosciences
    CNW Group

    SOL Global Portfolio Company Heavenly Rx, Ltd. Enters Into MOU for Business Combination with Therapix Biosciences

    TORONTO , Nov. 19, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (SOL.CN) (SOLCF) (9SB.F) announced today that its 40.7% owned portfolio company Heavenly  Rx, Ltd. ("Heavenly Rx") has entered into a memorandum of understanding ("MOU") with the US NASDAQ listed public company, Therapix Biosciences Ltd (TRPX), a speciality clinical-stage pharmaceutical company with a portfolio of technologies and assets based on cannabinoid pharmaceuticals, pursuant to which Therapix and Heavenly Rx have agreed to pursue a business combination. Pursuant to the MOU, the parties will negotiate a definitive agreement for a business combination between Therapix and Heavenly Rx, constituting a reverse takeover of Therapix by Heavenly Rx.